Meetings - The ASCO Post

A phase I clinical trial investigating the use of bacterial Clostridium novyi-NT spores as an injectable monotherapy had manageable toxicities and showed early clinical efficacy in patients with treat...

sarcoma

immunotherapy

By Jo Cavallo / CRI-CIMT-EATI-AACR Immunotherapy Conference

Patient-Partnered Genomics Study Identifies Immunotherapy as a Potential Treatment for Angiosarcomas

Angiosarcoma of the head, face, neck, or scalp is a rare cancer associated with high rates of local recurrence, distant metastasis, and poor prognosis. Because angiosarcoma is so rare, it is difficult...

solid tumors

immunotherapy

By Jo Cavallo / CRI-CIMT-EATI-AACR Immunotherapy Conference

Cancer Vaccine Shows Clinical Benefit in Phase I Study of Patients With HER2-Positive Cancers

A preclinical study showing that a vaccination with a recombinant adenovirus expressing a truncated ErbB-2 antigen can cure advanced established murine breast cancer as well as extensive established m...

CRI-CIMT-EATI-AACR Immunotherapy Conference

Bacterial Therapy Tolerable, Shows Early Activity in Patients With Advanced Solid Tumors

Patient-Partnered Genomics Study Identifies Immunotherapy as a Potential Treatment for Angiosarcomas

Cancer Vaccine Shows Clinical Benefit in Phase I Study of Patients With HER2-Positive Cancers

Addition of Hyperthermic Intraperitoneal Chemotherapy to Surgery for Recurrent Ovarian Cancer

Penpulimab Combination Therapy for First-Line Treatment of Hepatocellular Carcinoma

Global Adaptive Platform Trial for Glioblastoma to Evaluate Novel ATM Kinase Inhibitor

Healthy Women May Have Aneuploid Epithelial Cells Resembling Breast Cancer

Perioperative Toripalimab in Locoregionally Advanced Nasopharyngeal Carcinoma